Rapid construction of EGFP labled recombinant adenovirus containing hVEGF165 and its expression in haematopoietic cells

Zhong Zhaodong, Zou Ping, Huang Shiang, Hu Zhongbo, Liu Lingbo, Lu Yunping

Current Medical Science ›› 2003, Vol. 23 ›› Issue (2) : 4-6.

Current Medical Science ›› 2003, Vol. 23 ›› Issue (2) : 4-6. DOI: 10.1007/BF02829447
Article

Rapid construction of EGFP labled recombinant adenovirus containing hVEGF165 and its expression in haematopoietic cells

Author information +
History +

Abstract

By using AdEasy system, which is based on the homologous recombination in bacteria, an EGFP labeled recombinant adenovirus vector containing hVEGF165 was constructed quickly and efficiently expressed in mouse haematopoietic cells, First, hVEGF165 coding sequence was subcloned into shuttle plasmid pAdTrack-CMV, then cotransformed with adenoviral backbone vector pAdEasy-1 into E. coli strain BJ5183. The recombinant adenoviral plasmid was transfected into HEK293 cells to assembly replication-defective adenovirus Ad-EGFP/hVEGF165. The expression of EGFP could be easily detected. The rate of EGFP positive mouse bone marrow mononuclear cells by flow cytometric analysis was 27.3% (MOI=100), and the expression of hVEGF165 protein in the supernatant was (1385±332) pg/106 cells. These results suggest that the construction of adenovirus vector by homologous recombination in bacteria features high efficiency and simplicity. The prepared high titer Ad-EGFP/hVEGF165 can be used an efficient helpful vector to infect hematopoietic cells.

Keywords

EGFP / vascular endothelial growth factor / adenovirus / homologous recombination / haematopoietic cells

Cite this article

Download citation ▾
Zhong Zhaodong, Zou Ping, Huang Shiang, Hu Zhongbo, Liu Lingbo, Lu Yunping. Rapid construction of EGFP labled recombinant adenovirus containing hVEGF165 and its expression in haematopoietic cells. Current Medical Science, 2003, 23(2): 4‒6 https://doi.org/10.1007/BF02829447

References

[1]
GabrilovichD, IshidaT, OyamaT, et al.. Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo. Blood, 1998, 92: 4150-4150
CrossRef Google scholar
[2]
BautzF, RaffiS, KanzL, et al.. Expression and secretion of vascular endothelial growth factor-A by cutokine stimulated hematopoietic progenitor cell: Possible role in the hematopoietic microenvironment. Exp Hematol, 2000, 28: 700-700
CrossRef Google scholar
[3]
HattoriK, DiasS, HeissigB, et al.. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J Exp Med, 2001, 193: 1005-1005
CrossRef Google scholar
[4]
TraverD, ZonL I. Walking the walk: Migration and other common themes in blood and vascular development. Cell, 2002, 108: 731-731
CrossRef Google scholar
[5]
HeT C, ZhouS B, CostaL D, et al.. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA, 1998, 95: 2509-2509
CrossRef Google scholar
[6]
LimonA, BrionesJ, PuigT, et al.. High-titer retroviral vectors containing the enhanced green flurescent protein gene for efficient expression in hematopoietic cells. Blood, 1997, 90: 3316-3316
CrossRef Google scholar
[7]
KellerG, LacaudG, RobertsonS. Development of the hematopoietic system in the mouse. Exp Hematol, 1999, 27: 777-777
CrossRef Google scholar
[8]
GauglerM H, SquibanC, ClarazM, et al.. Characterization of the response of human bone marrow endothelial cells to the in vitro irradiation. Br J Haematol, 1998, 10: 980-980
CrossRef Google scholar

Accesses

Citations

Detail

Sections
Recommended

/